Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-02 @ 8:18 AM
Study NCT ID:
NCT01779518
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2014-01-16
First Post:
2013-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Sponsor:
Gilead Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Post-transplant Hepatitis C | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HCV | View |
| None | Sustained Virologic Response | View |
| None | Direct Acting Antiviral | View |
| None | GS-7977 | View |
| None | Pegylated interferon | View |
| None | Ribavirin | View |
| None | Open Label | View |
| None | Sofosbuvir | View |
| None | Liver transplant | View |
| None | Hepatitis | View |
| None | Hepatitis, Chronic | View |
| None | Hepatitis C | View |
| None | Hepatitis C, Chronic | View |
| None | Liver Diseases | View |
| None | Digestive System Diseases | View |
| None | Hepatitis, Viral, Human | View |
| None | Virus Diseases | View |
| None | Enterovirus Infections | View |
| None | Picornaviridae Infections | View |
| None | RNA Virus Infections | View |
| None | Flaviviridae Infections | View |
| None | Antiviral Agents | View |
| None | Anti-Infective Agents | View |
| None | Therapeutic Uses | View |
| None | Pharmacologic Actions | View |
| None | Antimetabolites | View |
| None | Molecular Mechanisms of Pharmacological Action | View |